Business ❯Finance ❯Pharmaceuticals
Emcure Pharmaceuticals Novartis AG Sun Pharmaceutical Industries Novo Nordisk Sun Pharmaceutical Industries Ltd. Sanofi Q1 2024 Quarterly Report
The company announces strong Q4 FY25 results, a Rs 3 per share dividend, and plans for global growth through European acquisitions and regulatory approvals.